Objectives: There is a need for improved risk stratification in endometrial cancer to avoid unnecessary lymphadenectomies in cancers with low risk of lymph node metastasis (LNM). The aim is to develop an ultrasound-based model to calculate the individual risk of LNM. Methods: We used the IETA dataset (17 centres) of 1501 women with endometrial cancer undergoing expert ultrasound assessment prior to hysterectomy with or without lymphadenectomy. Missing data was multiply imputed. Candidate predictors were selected in expert discussions. A mixed effects logistic regression model was developed using the multivariate fractional polynomial algorithm and heuristic shrinkage. The performance of the model in new centres was evaluated using leave-centre-out cross-validation in terms of discrimination (AUC, sensitivity, specificity), calibration (intercept, slope, plots), and clinical utility (decision curves). Results: 691/1501 women (64%) underwent lymphadenectomy, with 127 cases of LNM (18%). The prediction model included age, months since the onset of abnormal bleeding, preoperative endometrial biopsy results, the extent of tumour spread and the anteposterior tumour/uterine diameter ratio seen on ultrasound. The AUC was 0.73 (95% CI 0.68 to 0.78) and predicted risks corresponded well to observed LNM frequencies. Based on biopsy results alone, 3 in 4 patients were classified as low risk (endometrioid grade 1-2), with a 35% sensitivity and 77% specificity. Based on the model, 3 in 4 women fell below the 20% risk of LNM cut-off, while reaching a better sensitivity and specificity (48 and 80%). At a risk cut-off of 5%, sensitivity was 98% and specificity was 11%. Conclusions: Based on biopsy results, clinical and ultrasound characteristics, we can reliably estimate LNM risk. The models' performance is comparable to that of published preoperative MRI-based models and could be used to identify patients with a low risk of LNM and aid in deciding who requires lymphadenectomy or sentinel node mapping. Objectives: To compare subjective assessment with objective measurements for the detection of deep myometrial invasion (MI) and cervical stromal invasion (CSI) in grade 1-2 versus grade 3/non-endometroid tumours. Methods: Prospective multicentre study on 1714 women with endometrial cancer undergoing standardised expert transvaginal ultrasound examination, where MI and CSI were evaluated subjectively and compared to objective measurements; tumour anteroposterior (AP) diameter, tumour/uterine AP ratio, minimal tumour-free margin, minimal tumour-free margin/uterine AP diameter, tumour volume (2D), and the distance from outer-cervical-os to lower margin of tumour (Dist-OCO). Histological assessment from hysterectomy was considered gold standard. Results: After exclusions, 1275 remained for analysis. Subjective assessment had a sensitivity and specificity of 70% and 80% to detect MI, and 49%, 94% to detect CSI. The best objective measurement to predict MI was tumour/uterine AP ratio at a cut-off of 0.52 (grade 1-2; 0.47, grade 3/non endometrioid tumours; 0.58), and CSI; Dist-OCO, cut-off of 23mm (grade 1-2; 23mm, grade 3/non endometrioid tumours; 21mm). To assess MI subjective evaluation was better than any objective measurement in grade 1-2 tumours, whereas in grade 3 tumours/non-endometrioid tumours, both techniques had a substantially lower specificity and the differences in between techniques were less obvious. To assess CSI, Dist-OCO at a cut-off of 23mm (AUC 0.75) had a comparable accuracy as subjective assessment in grade 1-2 tumours, while subjective assessment outperformed Dist-OCO in grade 3/non-endometrioid tumours. Conclusions: In grade 1-2 tumours subjective assessment of MI outperform objective measurements, while dist-OCO at a cut-off of 23 mm might be as good as subjective assessment for detecting CSI. In grade 3/non-endometrioid tumours both techniques perform similar in the assessment of MI, while subjective assessment is superior for the assessment of CSI.
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